Marathon Asset Management is a global investment manager specializing in credit and fixed income markets. The firm focuses on a variety of investment strategies, including private credit, direct lending, opportunistic credit, asset-based lending, and various forms of finance such as transportation, healthcare, and real estate. Marathon typically participates in private equity, post-IPO debt and equity rounds, and debt financing, managing a diverse portfolio of investment programs.

Notable portfolio companies include ADMA Biologics, Avenger Flight Group, Baudax Bio, Dermavant Sciences, Healogics, and Workhorse Group. Marathon's key partners and decision-makers bring extensive experience from leading financial institutions. The firm's investment philosophy emphasizes opportunistic investing and value creation through active management. Marathon also offers unique value-add services such as tailored financing solutions and strategic advisory to support the growth and success of its portfolio companies.